ATE536993T1 - Aminfunktionalisierte superparamagnetisierte nanoteilchen für die synthese von biokonjugaten - Google Patents

Aminfunktionalisierte superparamagnetisierte nanoteilchen für die synthese von biokonjugaten

Info

Publication number
ATE536993T1
ATE536993T1 AT03705645T AT03705645T ATE536993T1 AT E536993 T1 ATE536993 T1 AT E536993T1 AT 03705645 T AT03705645 T AT 03705645T AT 03705645 T AT03705645 T AT 03705645T AT E536993 T1 ATE536993 T1 AT E536993T1
Authority
AT
Austria
Prior art keywords
nanoparticles
amine
superparamagnetized
bioconjugates
synthesis
Prior art date
Application number
AT03705645T
Other languages
English (en)
Inventor
Debra Gaw
Lee Josephson
Original Assignee
Visen Medical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Visen Medical Inc filed Critical Visen Medical Inc
Application granted granted Critical
Publication of ATE536993T1 publication Critical patent/ATE536993T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1818—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles
    • A61K49/1821—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles
    • A61K49/1824—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles
    • A61K49/1827—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle
    • A61K49/1851—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle having a (super)(para)magnetic core coated or functionalised with an organic macromolecular compound, i.e. oligomeric, polymeric, dendrimeric organic molecule
    • A61K49/1854—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle having a (super)(para)magnetic core coated or functionalised with an organic macromolecular compound, i.e. oligomeric, polymeric, dendrimeric organic molecule the organic macromolecular compound being obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly(meth)acrylate, polyacrylamide, polyvinylpyrrolidone, polyvinylalcohol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5094—Microcapsules containing magnetic carrier material, e.g. ferrite for drug targeting
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nanotechnology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Radiology & Medical Imaging (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medical Informatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Peptides Or Proteins (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
AT03705645T 2002-01-02 2003-01-02 Aminfunktionalisierte superparamagnetisierte nanoteilchen für die synthese von biokonjugaten ATE536993T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34523302P 2002-01-02 2002-01-02
PCT/US2003/000051 WO2003057175A2 (en) 2002-01-02 2003-01-02 Amine functionalized superparamagnetic nanoparticles for the synthesis of bioconjugates and uses therefor

Publications (1)

Publication Number Publication Date
ATE536993T1 true ATE536993T1 (de) 2011-12-15

Family

ID=23354146

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03705645T ATE536993T1 (de) 2002-01-02 2003-01-02 Aminfunktionalisierte superparamagnetisierte nanoteilchen für die synthese von biokonjugaten

Country Status (5)

Country Link
US (2) US20030124194A1 (de)
EP (1) EP1469989B1 (de)
AT (1) ATE536993T1 (de)
AU (1) AU2003207438A1 (de)
WO (1) WO2003057175A2 (de)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE536993T1 (de) 2002-01-02 2011-12-15 Visen Medical Inc Aminfunktionalisierte superparamagnetisierte nanoteilchen für die synthese von biokonjugaten
US6797380B2 (en) * 2002-07-31 2004-09-28 General Electric Company Nanoparticle having an inorganic core
US7563507B2 (en) * 2002-08-16 2009-07-21 University Of Massachusetts Pyridine and related ligand compounds, functionalized nanoparticulate composites and methods of preparation
WO2004108902A2 (en) * 2003-06-04 2004-12-16 Visen Medical, Inc. Biocompatible fluorescent silicon nanoparticles
US20050014851A1 (en) * 2003-07-18 2005-01-20 Eastman Kodak Company Colloidal core-shell assemblies and methods of preparation
US20060263897A1 (en) * 2003-09-09 2006-11-23 Koninklijke Philips Electronics N.V. Nanoparticles for detecting analytes
ES2242528B1 (es) 2004-03-25 2006-12-01 Consejo Sup. Investig. Cientificas Nanoparticulas magneticas de metales nobles.
US20060293396A1 (en) * 2005-01-14 2006-12-28 Eastman Kodak Company Amine polymer-modified nanoparticulate carriers
US8288169B2 (en) * 2005-01-21 2012-10-16 Argylla Technologies Surface mediated self-assembly of nanoparticles
EP1721603A1 (de) * 2005-05-11 2006-11-15 Albert-Ludwigs-Universität Freiburg Nanopartikel geeignet für Biokonjugation
US8173819B2 (en) 2005-09-02 2012-05-08 Visen Medical, Inc. Nicotinic and picolinic acid derived near-infrared fluorophores
ES2612738T3 (es) * 2005-09-02 2017-05-18 Visen Medical, Inc. Agentes de formación de imágenes fluorescentes biocompatibles
JP5106397B2 (ja) 2005-09-02 2012-12-26 ビセン メディカル， インコーポレイテッド 生体適合性ｎ，ｎ−二置換スルホンアミド含有蛍光色素標識
DK1943016T3 (da) * 2005-10-14 2012-10-01 Vive Crop Prot Inc Kompositnanopartikler, nanopartikler og fremgangsmåder til fremstilling heraf
WO2007064301A1 (en) * 2005-11-30 2007-06-07 Agency For Science, Technology And Research Nanoparticle and methods therefor
US20070140974A1 (en) * 2005-12-15 2007-06-21 General Electric Company Targeted nanoparticles for magnetic resonance imaging
EP1973575B1 (de) * 2005-12-22 2019-07-24 Visen Medical, Inc. Biokompatibele fluoreszierende metalloxide nanopartikel
JP2009531302A (ja) * 2006-02-28 2009-09-03 メディカル リサーチ カウンシル 標的化酸化鉄ナノ粒子
WO2007109274A2 (en) * 2006-03-21 2007-09-27 Alza Corporation Hydratable polymeric ester matrix for drug electrotransport
US20100239864A1 (en) * 2006-03-27 2010-09-23 Tokyo Institute Of Technology Method of manufacturing polymer coated ferromagnetic particles and polymer coated ferromagnetic particles
US20080008654A1 (en) * 2006-07-07 2008-01-10 Boston Scientific Scimed, Inc. Medical devices having a temporary radiopaque coating
US8333993B1 (en) 2006-12-29 2012-12-18 University Of Central Florida Research Foundation, Inc. Synthesis of polymer coated ceria nanoparticles for biomedical applications
EP2118206B9 (de) 2007-02-09 2018-08-29 Visen Medical, Inc. Polycyclofarbstoffe und verwendung davon
US20080193766A1 (en) * 2007-02-13 2008-08-14 Northern Nanotechnologies Control of Transport to and from Nanoparticle Surfaces
WO2008109832A2 (en) * 2007-03-08 2008-09-12 Visen Medical, Inc. Viable near-infrared fluorochrome labeled cells and methods of making and using same
US8409463B1 (en) 2007-07-16 2013-04-02 University Of Central Florida Research Foundation, Inc. Aqueous method for making magnetic iron oxide nanoparticles
US9119391B1 (en) 2007-07-16 2015-09-01 University Of Central Florida Research Foundation, Inc. Polymer coated ceria nanoparticles for selective cytoprotection
US9057094B1 (en) 2007-10-25 2015-06-16 University Of Central Florida Research Foundation, Inc. Nanoparticle-mediated methods for antimicrobial susceptibility testing of bacteria
EP2244741B1 (de) 2008-01-18 2015-03-25 VisEn Medical, Inc. Fluoreszierende bildgebungsmittel
US8236284B1 (en) 2008-04-02 2012-08-07 University Of Central Florida Research Foundation, Inc. Multimodal, multifunctional polymer coated nanoparticles
US7645318B2 (en) * 2008-05-07 2010-01-12 Vive Nano, Inc. Producing nanoparticles using nanoscale polymer templates
US8324125B2 (en) * 2009-09-03 2012-12-04 The United States Of America As Represented By The Administrator Of The U.S. Environmental Protection Agency Magnetic nanoparticle-supported glutathione as a sustainable organocatalyst
CN102666879B (zh) 2009-10-30 2016-02-24 西北大学 模板化的纳米缀合物
JP2013526616A (ja) 2010-05-26 2013-06-24 ザ ジェネラル ホスピタル コーポレイション 磁性ナノ粒子
EP2707102B1 (de) 2011-05-09 2019-11-13 Visen Medical, Inc. Auf carboanhydrase zielende wirkstoffe sowie verfahren zu ihrer verwendung
EP2710151A4 (de) 2011-05-19 2014-12-10 Univ Central Florida Res Found Mikrobendetektion durch hybridisierung magnetischer entspannungsnanosensoren
US9958416B2 (en) 2011-11-23 2018-05-01 The General Hospital Corporation Analyte detection using magnetic hall effect
EP2831264B1 (de) 2012-03-30 2019-07-10 VisEn Medical, Inc. Bakterielle bildgebungsmittel und verfahren zur verwendung davon
KR20130113575A (ko) * 2012-04-06 2013-10-16 서울대학교산학협력단 산화철 나노복합체와 이를 포함하는 자기공명영상 ｔ2 조영제 및 이들의 제조 방법
KR101380900B1 (ko) * 2012-05-08 2014-04-10 포항공과대학교 산학협력단 나이트로 방향족 폭발물의 안정적인 검출을 위한 나노입자 표면 분자체의 합성과 이를 이용한 폭발물 검출 센서
EP2864051B1 (de) 2012-06-25 2020-09-23 The General Hospital Corporation Sortieren von partikeln unter verwendung von starken magnetfeldern
WO2014028057A1 (en) 2012-08-15 2014-02-20 Visen Medical, Inc. Prostate specific antigen agents and methods of using same for prostate cancer imaging
CA2904758A1 (en) * 2013-03-14 2014-09-25 Peroxyium, Inc., Delaware C Corp. Method of enhancing the biodistribution and tissue targeting properties of therapeutic ceo2 particles via nano-encapsulation and coating
CN105073761B (zh) 2013-03-15 2020-10-20 文森医学公司 用于体外和体内成像和检测的取代的硅杂蒽阳离子红至近红外荧光染料
EP2970674B1 (de) 2013-03-15 2018-12-12 VisEn Medical, Inc. 4,4-disubstituierte cyclohexyl-verbrückte heptamethin-cyanin-farbstoffe und verwendungen davon
US20140342388A1 (en) * 2013-04-04 2014-11-20 Yang Cai Reagent for labeling primary amine groups in proteins
CN104297219A (zh) * 2013-07-16 2015-01-21 上海乐宇生物科技有限公司 高灵敏度的三磷酸腺苷检测方法
EP3560591B1 (de) 2013-10-18 2021-02-17 The General Hospital Corporation Mikrofluidische sortierung unter verwendung von magnetfeldern mit hohem gradienten
EP3143386A4 (de) * 2014-05-12 2017-11-29 Qi, Huan Verfahren und system zur analytmessung
US10319502B2 (en) 2014-10-23 2019-06-11 Corning Incorporated Polymer-encapsulated magnetic nanoparticles
JP6649377B2 (ja) 2014-11-03 2020-02-19 ザ ジェネラル ホスピタル コーポレイション ミクロ流体装置による粒子の複合式分類および濃縮
EP3338806A1 (de) * 2016-12-21 2018-06-27 Université de Namur Verfahren zur funktionalisierung von nanopartikeln
EP3566720A1 (de) * 2018-05-08 2019-11-13 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Nanopartikel mit nichtkovalent gebundenen targeting-teilen zur verwendung in einem therapeutischen verfahren und zur nichtmedizinischen verwendung
US20230033556A1 (en) 2019-12-31 2023-02-02 Universidad De Santiago De Chile System and method for detecting a biological analyte, including a microorganism, by a change in the magnetic property of a substrate, using superparamangnetic nanoparticles
CN119034687B (zh) * 2024-07-19 2026-02-03 国氟新材料(广东)有限公司 一种含氟污泥脱水的可重复使用助滤剂及其制备方法

Family Cites Families (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5913521B2 (ja) * 1975-06-19 1984-03-30 メイトウサンギヨウ カブシキガイシヤ 磁性酸化鉄・デキストラン複合体の製造法
US4219335A (en) * 1978-09-18 1980-08-26 E. I. Du Pont De Nemours And Company Immunochemical testing using tagged reagents
US4369226A (en) * 1979-03-19 1983-01-18 California Institute Of Technology Polyglutaraldehyde synthesis and protein bonding substrates
US4438239A (en) * 1981-03-30 1984-03-20 California Institute Of Technology Microsphere coated substrate containing reactive aldehyde groups
US4452773A (en) * 1982-04-05 1984-06-05 Canadian Patents And Development Limited Magnetic iron-dextran microspheres
NO155316C (no) * 1982-04-23 1987-03-11 Sintef Fremgangsmaate for fremstilling av magnetiske polymerpartikler.
US4628037A (en) * 1983-05-12 1986-12-09 Advanced Magnetics, Inc. Binding assays employing magnetic particles
US5627027A (en) * 1986-04-18 1997-05-06 Carnegie Mellon University Cyanine dyes as labeling reagents for detection of biological and other materials by luminescence methods
US5569587A (en) * 1986-04-18 1996-10-29 Carnegie Mellon University Method for labeling and detecting materials employing luminescent arysulfonate cyanine dyes
US5268486A (en) * 1986-04-18 1993-12-07 Carnegie-Mellon Unversity Method for labeling and detecting materials employing arylsulfonate cyanine dyes
US5262176A (en) * 1986-07-03 1993-11-16 Advanced Magnetics, Inc. Synthesis of polysaccharide covered superparamagnetic oxide colloids
US5478576A (en) * 1986-07-03 1995-12-26 Advanced Magnetics, Inc. Arabinogalactan derivatives and uses thereof
US5395688A (en) * 1987-10-26 1995-03-07 Baxter Diagnostics Inc. Magnetically responsive fluorescent polymer particles
US5512439A (en) * 1988-11-21 1996-04-30 Dynal As Oligonucleotide-linked magnetic particles and uses thereof
US4981977A (en) * 1989-06-09 1991-01-01 Carnegie-Mellon University Intermediate for and fluorescent cyanine dyes containing carboxylic acid groups
US5698271A (en) * 1989-08-22 1997-12-16 Immunivest Corporation Methods for the manufacture of magnetically responsive particles
JP2726520B2 (ja) * 1989-10-20 1998-03-11 名糖産業株式会社 有機磁性複合体
US5164297A (en) * 1990-05-03 1992-11-17 Advanced Magnetics Inc. Solvent mediated relaxation assay system
WO1992022586A1 (fr) * 1991-06-11 1992-12-23 Meito Sangyo Kabushiki Kaisha Composite oxyde comprenant du carboxypolysaccharide hydrosoluble et de l'oxyde de fer magnetique
US5445970A (en) * 1992-03-20 1995-08-29 Abbott Laboratories Magnetically assisted binding assays using magnetically labeled binding members
JPH08501097A (ja) * 1992-09-04 1996-02-06 ザ ゼネラル ホスピタル コーポレーション 臨床診断及び治療用部分を含む生体適合性ポリマー
US5808044A (en) * 1993-01-22 1998-09-15 Pharmacia Biotech Inc. Indocarbocyanine and benzindocarbocyanine phosphoramidites
US5928958A (en) * 1994-07-27 1999-07-27 Pilgrimm; Herbert Superparamagnetic particles, process for their manufacture and usage
US6127134A (en) * 1995-04-20 2000-10-03 Carnegie Mellon University Difference gel electrophoresis using matched multiple dyes
US5539658A (en) * 1995-05-16 1996-07-23 Minnesota Mining And Manufacturing Company Electronic presentation system using portable storage media
US6008373A (en) * 1995-06-07 1999-12-28 Carnegie Mellon University Fluorescent labeling complexes with large stokes shift formed by coupling together cyanine and other fluorochromes capable of resonance energy transfer
IT1276833B1 (it) * 1995-10-09 1997-11-03 Sorin Biomedica Cardio Spa Coloranti fluorescenti della famiglia della solfo benz e indocianina
US6004536A (en) * 1995-11-14 1999-12-21 Molecular Probes, Inc. Lipophilic cyanine dyes with enchanced aqueous solubilty
US5981507A (en) * 1995-12-14 1999-11-09 Advanced Magnetics, Inc. Polymeric carriers linked to nucleotide analogues via a phosphoramide bond
CA2251985A1 (en) 1996-04-19 1997-10-30 Alan Lewis Hamilton Squarate dyes and their use in fluorescent sequencing method
FR2749082B1 (fr) * 1996-05-24 1998-06-26 Bio Merieux Particules superparamagnetiques et monodispersees
US6316265B1 (en) * 1997-03-13 2001-11-13 Abbott Laboratories Determination of % glycated hemoglobin
US5877310A (en) * 1997-04-25 1999-03-02 Carnegie Mellon University Glycoconjugated fluorescent labeling reagents
US6248539B1 (en) * 1997-09-05 2001-06-19 The Scripps Research Institute Porous semiconductor-based optical interferometric sensor
US6074884A (en) * 1997-10-09 2000-06-13 Coulter International Corp. Stable protein-nickel particles and methods of production and use thereof
US6046585A (en) * 1997-11-21 2000-04-04 Quantum Design, Inc. Method and apparatus for making quantitative measurements of localized accumulations of target particles having magnetic particles bound thereto
US6133445A (en) * 1997-12-17 2000-10-17 Carnegie Mellon University Rigidized trimethine cyanine dyes
DE69815282T2 (de) * 1997-12-25 2004-05-06 Tosoh Corp., Shinnanyo Magnetischer Träger, seine Herstellung, und Verfahren zum Extrahieren von Nukleinsäuren
AU3386399A (en) 1998-04-08 1999-10-25 Ewald A. Terpetschnig Luminescent compounds
US6002003A (en) * 1998-04-14 1999-12-14 Beckman Instruments, Inc. Cyanine dye activating group with improved coupling selectivity
US6083486A (en) * 1998-05-14 2000-07-04 The General Hospital Corporation Intramolecularly-quenched near infrared fluorescent probes
US6592847B1 (en) * 1998-05-14 2003-07-15 The General Hospital Corporation Intramolecularly-quenched near infrared flourescent probes
JP5064612B2 (ja) 1999-04-09 2012-10-31 エーエムエージー ファーマシューティカルズ，インコーポレイテッド 還元された炭水化物類及び炭水化物誘導体で被覆された熱的に安定なコロイド状酸化鉄
ATE284433T1 (de) * 1999-07-02 2004-12-15 Visen Medical Inc Fluorescierende cyaninlabels mit einem sulphamidobrückenglied
DE10046508A1 (de) 1999-09-14 2001-04-05 Tridelta Bio Medical Gmbh Magnetische Nanoteilchen mit biochemischer Wikrsamkeit und Verfahren zu ihrer Herstellung sowie ihre Verwendung
DE60020584T2 (de) 1999-09-20 2006-04-27 Fuji Photo Film Co., Ltd., Minami-Ashigara Verbindungen zur fluoreszenz-kennzeichnung
US6548264B1 (en) * 2000-05-17 2003-04-15 University Of Florida Coated nanoparticles
US6734000B2 (en) * 2000-10-12 2004-05-11 Regents Of The University Of California Nanoporous silicon support containing macropores for use as a bioreactor
US6615063B1 (en) * 2000-11-27 2003-09-02 The General Hospital Corporation Fluorescence-mediated molecular tomography
EP1209205A1 (de) * 2000-11-28 2002-05-29 Innosense S.r.l. Verbesserte Verfahren und Methode zur Herstellung von asymmetrischen monofunktionalisierten Indocyaninmarkern sowie erhaltene Verbindungen
EP1221465A1 (de) * 2001-01-03 2002-07-10 Innosense S.r.l. Symmetrische, monofunktionalisierte Polymethinfarbstoffe als Markierungsreagenzien
US20030044353A1 (en) * 2001-01-05 2003-03-06 Ralph Weissleder Activatable imaging probes
US20030092029A1 (en) * 2001-06-06 2003-05-15 Lee Josephson Magneitc-nanoparticle conjugates and methods of use
BR0210616A (pt) * 2001-06-28 2004-09-28 Pfizer Prod Inc Indóis, benzofuranos e benzotiofenos substituìdos com triamida, composição farmacêutica, uso dos referidos compostos, bem como processo para preparação dos mesmos
US7463615B2 (en) 2001-07-13 2008-12-09 Qualcomm, Incorporated System and method for extended SIP headers for CDMA parameters
ATE536993T1 (de) 2002-01-02 2011-12-15 Visen Medical Inc Aminfunktionalisierte superparamagnetisierte nanoteilchen für die synthese von biokonjugaten
WO2003061711A2 (en) * 2002-01-16 2003-07-31 Visen Medical, Inc. Chromophore probes for optical imaging
AU2003225763A1 (en) 2002-03-11 2003-09-29 Visen Medical, Inc. Optical imaging probes
US7189417B2 (en) * 2002-05-01 2007-03-13 The Trustees Of The University Of Pennsylvania Nanometer-sized carrier medium
US20060169843A1 (en) * 2002-05-14 2006-08-03 Barrs Chris C Release connectors (quick release pull tab)
EP2410315B1 (de) 2002-06-04 2020-04-01 Visen Medical, Inc. Bildgebungsdatenträger mit willkürlichen Geometrien bei Kontakt- und kontaktloser Tomographie
US7303741B2 (en) 2002-09-23 2007-12-04 General Electric Company Systems and methods for high-resolution in vivo imaging of biochemical activity in a living organism
WO2004083902A2 (en) 2002-10-25 2004-09-30 Georgia Tech Research Corporation Multifunctional magnetic nanoparticle probes for intracellular molecular imaging and monitoring
WO2004108902A2 (en) 2003-06-04 2004-12-16 Visen Medical, Inc. Biocompatible fluorescent silicon nanoparticles
WO2005017539A2 (en) 2003-08-14 2005-02-24 The General Hospital Corporation Imaging pathology
WO2006010083A2 (en) 2004-07-08 2006-01-26 Molecular Therapeutics, Inc. Biodegradable nanoparticles
WO2006028129A1 (ja) 2004-09-10 2006-03-16 Toray Industries, Inc. 医薬品製剤
US20070292688A1 (en) 2005-08-18 2007-12-20 Eastman Kodak Company Silylamine modified nanoparticulate carriers
US8173819B2 (en) 2005-09-02 2012-05-08 Visen Medical, Inc. Nicotinic and picolinic acid derived near-infrared fluorophores
ES2612738T3 (es) 2005-09-02 2017-05-18 Visen Medical, Inc. Agentes de formación de imágenes fluorescentes biocompatibles
JP5106397B2 (ja) 2005-09-02 2012-12-26 ビセン メディカル， インコーポレイテッド 生体適合性ｎ，ｎ−二置換スルホンアミド含有蛍光色素標識
EP1787659B1 (de) 2005-11-16 2017-03-22 Exchange Imaging Technologies GmbH Fluoreszenz-Nanopartikel
EP1973575B1 (de) 2005-12-22 2019-07-24 Visen Medical, Inc. Biokompatibele fluoreszierende metalloxide nanopartikel

Also Published As

Publication number Publication date
EP1469989A4 (de) 2006-07-05
WO2003057175A3 (en) 2003-11-13
WO2003057175A2 (en) 2003-07-17
US8420055B2 (en) 2013-04-16
US20090068115A1 (en) 2009-03-12
AU2003207438A8 (en) 2003-07-24
EP1469989B1 (de) 2011-12-14
EP1469989A2 (de) 2004-10-27
AU2003207438A1 (en) 2003-07-24
US20030124194A1 (en) 2003-07-03

Similar Documents

Publication Publication Date Title
AU2003207438A8 (en) Amine functionalized superparamagnetic nanoparticles for the synthesis of bioconjugates and uses therefor
Kaur et al. Lysine-functionalized nanodiamonds: synthesis, physiochemical characterization, and nucleic acid binding studies
Shi et al. Dendrimer‐entrapped gold nanoparticles as a platform for cancer‐cell targeting and imaging
CN102313725B (zh) 一种溶菌酶分子印迹-量子点纳米荧光探针的制备方法
Li et al. Surface molecular imprinting onto fluorescein-coated magnetic nanoparticles via reversible addition fragmentation chain transfer polymerization: A facile three-in-one system for recognition and separation of endocrine disrupting chemicals
Badri et al. Modification of graphene/graphene oxide with polymer brushes using controlled/living radical polymerization
Xiao et al. Fluorescent nanomaterials combined with molecular imprinting polymer: synthesis, analytical applications, and challenges
US4822867A (en) Protein polymer grafts
CN106475068A (zh) 苯硼酸功能化的氧化石墨烯复合纳米材料及其制备和应用
Yu et al. Advances in synthesis and application of amphoteric polymer-based water treatment agents
Ji et al. Facile fabrication of zwitterionic magnetic composites by one-step distillation-precipitation polymerization for highly specific enrichment of glycopeptides
Jiang et al. Synthesis of biotinylated α-D-mannoside or N-acetyl β-D-glucosaminoside decorated gold nanoparticles: study of their biomolecular recognition with Con A and WGA lectins
Ma et al. Multi-targeting magnetic hyaluronan capsules efficiently capturing circulating tumor cells
Bayrakci et al. Novel humic acid-bonded magnetite nanoparticles for protein immobilization
Berghaus et al. Productive encounter: molecularly imprinted nanoparticles prepared using magnetic templates
Yang et al. pH-Responsive magnetic nanospheres for the reversibly selective capture and release of glycoproteins
WO2010044752A1 (en) Amphiphilic polymers and nanocrystals coated therewith
Cui et al. Compartmentalization and unidirectional cross-domain molecule shuttling of organometallic single-chain nanoparticles
Peiris et al. Assembly of linear nano-chains from iron oxide nanospheres with asymmetric surface chemistry
JP2019073673A (ja) 自己修復性ゲル
Huang et al. Facile syntheses of cucurbit [6] uril-anchored polymers and their noncovalent modification
Sedlacek et al. Multifunctional poly (2-ethyl-2-oxazoline) copolymers containing dithiolane and pentafluorophenyl esters as effective reactive linkers for gold surface coatings
CN103435781A (zh) 一种环氧树脂固化剂及其制备方法与应用
Wang et al. Synergetic enhancement: Imprinted magnetic microspheres based on the thiol-ene-amine conjugation and metal coordination for selective recognition of BSA
CN119912937A (zh) 一种Tosyl修饰磁性时间分辨荧光微球及制备方法和应用